179 related articles for article (PubMed ID: 1732059)
21. Preoperative idoxuridine and radiation for large soft tissue sarcomas: clinical results with five-year follow-up.
Sondak VK; Robertson JM; Sussman JJ; Saran PA; Chang AE; Lawrence TS
Ann Surg Oncol; 1998 Mar; 5(2):106-12. PubMed ID: 9527262
[TBL] [Abstract][Full Text] [Related]
22. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
Chi KH; Kunugi KA; Kinsella TJ
Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
[TBL] [Abstract][Full Text] [Related]
23. Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer.
Kotelnikov VM; Coon JS; Taylor S; Hutchinson J; Panje W; Caldareill DD; LaFollette S; Preisler HD
Head Neck; 1996; 18(6):522-8. PubMed ID: 8902565
[TBL] [Abstract][Full Text] [Related]
24. Incorporation of iododeoxyuridine into DNA of granulocytes in patients.
Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM
Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659
[TBL] [Abstract][Full Text] [Related]
25. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
[TBL] [Abstract][Full Text] [Related]
26. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
[TBL] [Abstract][Full Text] [Related]
27. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines.
Uhl V; Phillips TL; Ross GY; Bodell WJ; Rasmussen J
Int J Radiat Oncol Biol Phys; 1992; 22(3):489-94. PubMed ID: 1735685
[TBL] [Abstract][Full Text] [Related]
28. Proliferation kinetics of recruited cells in a mouse mammary carcinoma.
Pollack A; Terry NH; White RA; Cao S; Meistrich ML; Milas L
Cancer Res; 1994 Feb; 54(3):811-7. PubMed ID: 8306344
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
[TBL] [Abstract][Full Text] [Related]
30. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
[TBL] [Abstract][Full Text] [Related]
31. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
[TBL] [Abstract][Full Text] [Related]
32. Analysis of 5-iodo-2'-deoxyuridine incorporation in murine melanoma for photon activation therapy.
Laster BH; Popenoe EA; Wielopolski L; Commerford SL; Gahbauer R; Goodman J; Meek A; Fairchild RG
Radiother Oncol; 1990 Oct; 19(2):169-78. PubMed ID: 2255770
[TBL] [Abstract][Full Text] [Related]
33. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.
Hainsworth JD; Meluch AA; Greco FA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-38-S19-42. PubMed ID: 9427264
[TBL] [Abstract][Full Text] [Related]
35. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
36. Intravenous delivery of 5'-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: results of a pilot study.
Epstein AH; Lebovics RS; Van Waes C; Smith J; Okunieff P; Cook JA
Laryngoscope; 1998 Jul; 108(7):1090-4. PubMed ID: 9665262
[TBL] [Abstract][Full Text] [Related]
37. The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1393-8. PubMed ID: 2370189
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas.
Corvó R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Orecchia R; Benasso M; Numico GM; Merlano M; Margarino G; Vitale V
Clin Cancer Res; 1997 Nov; 3(11):1993-7. PubMed ID: 9815589
[TBL] [Abstract][Full Text] [Related]
40. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma.
Steinberg L; Hassan M; Olmsted L; Sharan V; Stepnick D; Hoppel C; Mugharbil A; Subramanyan S; McGloin B; Mackay W; Strauss M
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
